FI943569A7 - Hyviä liukenemisominaisuuksia omaavia farmaseuttisia koostumuksia - Google Patents

Hyviä liukenemisominaisuuksia omaavia farmaseuttisia koostumuksia Download PDF

Info

Publication number
FI943569A7
FI943569A7 FI943569A FI943569A FI943569A7 FI 943569 A7 FI943569 A7 FI 943569A7 FI 943569 A FI943569 A FI 943569A FI 943569 A FI943569 A FI 943569A FI 943569 A7 FI943569 A7 FI 943569A7
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
dissolution properties
good dissolution
good
properties
Prior art date
Application number
FI943569A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943569L (fi
FI943569A0 (fi
Inventor
Faranak Nikfar
Robert L Jerzewski
Abu T M Serajuddin
Nemichand B Jain
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI943569A0 publication Critical patent/FI943569A0/fi
Publication of FI943569L publication Critical patent/FI943569L/fi
Publication of FI943569A7 publication Critical patent/FI943569A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI943569A 1993-08-02 1994-07-29 Hyviä liukenemisominaisuuksia omaavia farmaseuttisia koostumuksia FI943569A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10080293A 1993-08-02 1993-08-02

Publications (3)

Publication Number Publication Date
FI943569A0 FI943569A0 (fi) 1994-07-29
FI943569L FI943569L (fi) 1995-02-03
FI943569A7 true FI943569A7 (fi) 1995-02-03

Family

ID=22281616

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943569A FI943569A7 (fi) 1993-08-02 1994-07-29 Hyviä liukenemisominaisuuksia omaavia farmaseuttisia koostumuksia

Country Status (15)

Country Link
EP (1) EP0638310A1 (show.php)
JP (1) JPH07145052A (show.php)
KR (1) KR950005309A (show.php)
CN (1) CN1118254A (show.php)
AU (1) AU6878294A (show.php)
CA (1) CA2129099A1 (show.php)
CZ (1) CZ181094A3 (show.php)
FI (1) FI943569A7 (show.php)
HU (1) HUT70951A (show.php)
IL (1) IL110376A (show.php)
NO (1) NO942854L (show.php)
NZ (1) NZ264129A (show.php)
PL (1) PL304508A1 (show.php)
RU (1) RU94028273A (show.php)
ZA (1) ZA945672B (show.php)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
CN1195500C (zh) 1998-05-18 2005-04-06 武田药品工业株式会社 可口腔崩解的片剂
CA2581111A1 (en) 1998-07-28 2000-02-10 Takeda Pharmaceutical Company Limited Rapidly disintegrable solid preparation
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
JP4698000B2 (ja) * 2000-06-27 2011-06-08 旭化成ケミカルズ株式会社 水易溶性薬物含有錠剤
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
DE10341414A1 (de) * 2003-09-05 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Oral zu applizierende Darreichungsform für schwerlösliche saure und amphotere Wirkstoffe
CN100438914C (zh) * 2003-10-15 2008-12-03 富士化学工业株式会社 用于口腔内快速崩解的片剂的组合物
JP3841804B2 (ja) 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
US8349361B2 (en) 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
EA015304B1 (ru) 2006-08-03 2011-06-30 Нитек Фарма Аг Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
MY149356A (en) 2007-03-29 2013-08-30 Daiichi Sankyo Co Ltd Pharmaceutical composition
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
GB201400034D0 (en) * 2014-01-02 2014-02-19 Astrazeneca Ab Pharmaceutical Compositions comprising AZD9291
EP3804717A1 (en) 2014-05-16 2021-04-14 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating systemic sclerosis or pulmonary arterial hypertension
US12161632B2 (en) 2014-05-16 2024-12-10 Cumberland Pharmaceuticals Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
MX2017017155A (es) 2015-06-30 2018-08-09 Cumberland Pharmaceuticals Inc Antagonistas del receptor de tromboxano en erea/asma.
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
CN109310646A (zh) 2016-05-05 2019-02-05 阿奎斯蒂弗医疗股份有限公司 增强递送的肾上腺素组合物
EP3454850B1 (en) 2016-05-11 2023-06-21 Cumberland Pharmaceuticals Inc. Compositions and methods of treating muscular dystrophy with thromboxane-a2 receptor antagonists
US12465564B2 (en) 2021-10-25 2025-11-11 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100889A (en) * 1989-04-03 1992-03-31 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
DD299186A5 (de) * 1990-10-01 1992-04-02 E.R. Squibb U. Sons,Inc.,Us Phenylen-7-oxabicycloheptyl-substituierte heterocycloamid-prostaglandinanaloga

Also Published As

Publication number Publication date
CN1118254A (zh) 1996-03-13
EP0638310A1 (en) 1995-02-15
CZ181094A3 (en) 1995-02-15
AU6878294A (en) 1995-02-09
CA2129099A1 (en) 1995-02-03
NO942854L (no) 1995-02-03
RU94028273A (ru) 1996-11-10
FI943569L (fi) 1995-02-03
IL110376A0 (en) 1994-10-21
FI943569A0 (fi) 1994-07-29
KR950005309A (ko) 1995-03-20
HU9402254D0 (en) 1994-09-28
IL110376A (en) 1998-08-16
NO942854D0 (show.php) 1994-08-01
NZ264129A (en) 1996-05-28
PL304508A1 (en) 1995-02-06
JPH07145052A (ja) 1995-06-06
ZA945672B (en) 1995-03-06
HUT70951A (en) 1995-11-28

Similar Documents

Publication Publication Date Title
FI943569L (fi) Hyviä liukenemisominaisuuksia omaavia farmaseuttisia koostumuksia
FI944832L (fi) Farmaseuttinen koostumus
FI20071025L (fi) Farmaseuttisia koostumuksia
FI923582L (fi) Farmaceutisk sferoidkomposition
FI955144L (fi) Päällystetyt farmaseuttiset koostumukset
ITMI932540A0 (it) Composizione farmaceutica
IT1246445B (it) Composizioni farmaceutiche con migliorate proprieta' di dissoluzione.
BR9509688A (pt) Composto e composição farmacêutica
FI943705L (fi) Farmaseuttiset koostumukset
BR9507768A (pt) Composição farmacêutica
FI940726L (fi) Farmaseuttiset koostumukset
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
DE69413111D1 (de) Shampoozusammensetzung
LV10579A (lv) Farmaceitiska kompozicija
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI954050A7 (fi) Lääkekoostumuksia
FI962738A0 (fi) Farmaseuttiset koostumukset
BR9505130A (pt) Composto e composiçao farmacêutica
ITMI932543A0 (it) Composizione farmaceutica
BR1100200A (pt) Composição farmacêutica
BR1100809A (pt) Composto e composição farmacêutica
BR1100293A (pt) Composto e composição farmacêutica
DK0723452T3 (da) Pharmaceutisk antacidsammensætning
ITMI930181A1 (it) Composizione farmaceutica contenente n-acetil-cisteina
SE9402437D0 (sv) Pharmaceutical composition